World Library  
My Account |  Register |  Help  
  
Flag as Inappropriate
Email this Article

Dasotraline

Article Id: WHEBN0022604651
Reproduction Date:

Title: Dasotraline  
Author: World Heritage Encyclopedia
Language: English
Subject: Serotonin–norepinephrine–dopamine reuptake inhibitor, Benzyl cyanide
Collection:
Publisher: World Heritage Encyclopedia
Publication
Date:
 

Dasotraline

Dasotraline
Systematic (IUPAC) name
(1R,4S)-4-(3,4-Dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthalenamine
Clinical data
Legal status
?
Identifiers
CAS number
ATC code ?
PubChem
ChemSpider  N
Chemical data
Formula C16H15Cl2N 
 N   

Dasotraline (INN;[1] SEP-225,289) is an antidepressant drug, which was being developed by Sepracor. It is a so-called triple reuptake inhibitor (TRI).[2][3][4][5]

References

  1. ^ "WHO Drug Information, Vol. 27, No. 4, 2013 Proposed INN: List 110". WHO. Retrieved 4 November 2014. 
  2. ^ Chen Z, Skolnick P (September 2007). "Triple uptake inhibitors: therapeutic potential in depression and beyond". Expert Opin Investig Drugs 16 (9): 1365–77. PMID 17714023. doi:10.1517/13543784.16.9.1365. 
  3. ^ DeLorenzo C, Lichenstein S, Schaefer K, Dunn J, Marshall R, Organisak L, Kharidia J, Robertson B, Mann JJ, Parsey RV (July 2011). "SEP-225289 serotonin and dopamine transporter occupancy: a PET study". J. Nucl. Med. 52 (7): 1150–5. PMC 3856248. PMID 21680689. doi:10.2967/jnumed.110.084525. 
  4. ^ Ziegler, L.; Küffer, G.; Euler, E.; Wilhelm, K. (1990). "Arthrographic imaging of ganglions of the hand". RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin 153 (2): 143–146. PMID 2168068. doi:10.1055/s-2008-1033352. 
  5. ^ Guiard, B. (2009). "P.1.c.059 Electrophysiological properties of the triple reuptake inhibitor SEP 225289 on monoaminergic neurons". European Neuropsychopharmacology 19: S285. doi:10.1016/S0924-977X(09)70419-5. 

Further reading

Liming Shao Patent
  • US application 2007203111, Shao L, Wang F, Malcolm SC, Hewitt MC, Bush LR, Ma J, Varney MA, Campbell U, Engel SR, Hardy LW, Koch P, Campbell JE, "Cycloalkylamines as monoamine reuptake inhibitors", published 2007-08-30, assigned to Sepracor Inc. 
Asymmetry Patent
  • US patent 7129378, Han X, Krishnamurthy D, Senanayake CH, Lu Z-H, "Method of preparing amine stereoisomers", published 2005-07-28, assigned to Apsinterm LLC 


This article was sourced from Creative Commons Attribution-ShareAlike License; additional terms may apply. World Heritage Encyclopedia content is assembled from numerous content providers, Open Access Publishing, and in compliance with The Fair Access to Science and Technology Research Act (FASTR), Wikimedia Foundation, Inc., Public Library of Science, The Encyclopedia of Life, Open Book Publishers (OBP), PubMed, U.S. National Library of Medicine, National Center for Biotechnology Information, U.S. National Library of Medicine, National Institutes of Health (NIH), U.S. Department of Health & Human Services, and USA.gov, which sources content from all federal, state, local, tribal, and territorial government publication portals (.gov, .mil, .edu). Funding for USA.gov and content contributors is made possible from the U.S. Congress, E-Government Act of 2002.
 
Crowd sourced content that is contributed to World Heritage Encyclopedia is peer reviewed and edited by our editorial staff to ensure quality scholarly research articles.
 
By using this site, you agree to the Terms of Use and Privacy Policy. World Heritage Encyclopedia™ is a registered trademark of the World Public Library Association, a non-profit organization.
 


Copyright © World Library Foundation. All rights reserved. eBooks from Project Gutenberg are sponsored by the World Library Foundation,
a 501c(4) Member's Support Non-Profit Organization, and is NOT affiliated with any governmental agency or department.